Delivery Order SPE2DB20D3103-SPE2DB25FN8G6
Award Date
5/14/25
Potential Completion Date
5/15/25
Potential Value
$9.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,065.38, is for the delivery of LEUPROLIDE 2WK 14 MG/2.8 ML KTS, a pharmaceutical product. The contract has a period of performance ending on March 24, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is a for-profit organization and has no set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LEUPROLIDE 2WK 14 MG/2.8 ML KTS, a specialty medication, with a ceiling value of $3,570.36 and a period of performance through February 25, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,869.12 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of leuprolide, a specialty injectable medication, to support military treatment programs and facilities. This delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and AmerisourceBergen...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the medication Leuprolide 2WK 14 MG/2.8 ML KTS. The contract has a ceiling value of $69,876.47 and is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999 through December 2025. The contract is for a Firm Fixed Price and is not set aside for any specific business type....
This federal contract award, identified as SPE2DB22D2206|SPE2DB25FGP49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,696.28 delivery order contract is for the supply of LEUPROLIDE 2WK 14 MG/2.8 ML KTS, a pharmaceutical product. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,818,331 units of Lupron Depot 45 mg 6-month kits. The contract has a ceiling value of $4,206.70 and a completion date of September 17, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Lupron Depot-Ped 45 mg 6-month kits. The contract has a total ceiling value of $49,844.74 and a completion date of February 6, 2025. It is a firm-fixed-price contract, and no set-aside designation was used. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,694.94 firm fixed-price contract is for the delivery of 4,566,796,274 units of the drug Lupron Depot 3.75 mg kits. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,112,754 units of Lupron Depot 45 mg 6-month kits, a medication used for the treatment of various medical conditions. The contract has a ceiling value of $17,108.30 and is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $1,829.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of leuprolide 2-week kits, a specialty medication, to support military healthcare programs. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...